⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Mark CrucianiMD

Rheumatology · Scranton, PA 18509

NPI: 1235171646

Share:

44

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

5,277

Total Claims

$864K

Drug Cost

347

Beneficiaries

$2,490

Cost/Patient

Risk Score Breakdown 44/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 5,101 Rheumatology providers

+858%

Opioid rate vs peers

38.9% vs 4.1% avg

-59%

Cost per patient vs peers

$2,490 vs $6,039 avg

-33%

Brand preference vs peers

5.1% vs 7.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 858% above the average for Rheumatology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

38.9%

Opioid Rate

2,053

Opioid Claims

$162K

Opioid Cost

24.0%

Long-Acting Rate

This provider's opioid prescribing rate of 38.9% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

95% generic

Brand: 270 claims · $726K

Generic: 5,007 claims · $138K

Patient Profile

69

Avg Age

70%

Female

1.33

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About